Back

Long-term cardiac adverse effects after modern Hodgkins lymphoma treatment

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Chronic heart failure - Cardiotoxicity of drugs Cardiotoxicity of Drugs and Other Therapies ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Anders Wold Bjerring

Oslo University Hospital Rikshospitalet, Oslo (Norway)

3 More presentations in this session

Presentation thumbnail
Response to heart failure treatment in patients with anthracyclines and trastuzumab induced left ventricular dysfunction.
Doctor S. del Castillo (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Cardiac pressure overload exposes hidden anthracycline-induced cardiotoxicity: Results from a preclinical large-animal trial
Mr C. Galan (Madrid, ES)
Abstract Slides
Presentation thumbnail
Usefulness of ultra-sensitive troponin to predict anthracyclines and trastuzumab related cardiac dysfunction
Doctor S. del Castillo (Buenos Aires, AR)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - Cardiotoxicity of drugs

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Session
Chronic kidney disease and heart failure
thumbnail
Congress Session
Rare causes of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources